News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Ekos Announces Two More Pulmonary Embolism Clinical Studies



5/3/2012 10:28:53 AM

BOTHELL, Wash.--(BUSINESS WIRE)--EKOS Corporation today announced the launch of two more landmark clinical studies named SEATTLE I & II, intended to further establish the safety and efficacy of its unique, ultrasound-accelerated thrombolysis in treating patients with life-threatening pulmonary embolism (PE).

Read at BioSpace.com


comments powered by Disqus
Ekos
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES